Why did Trump fire the labor statistics chief?
How are new tariffs impacting global markets?
What caused Tesla’s stock to fall recently?
Why are US job growth numbers disappointing?
How is AI spending affecting Big Tech profits?
What’s behind Figma’s record-breaking IPO?
How did weak jobs report affect Treasury yields?
Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales
benzinga.com/analyst-stock-ratings/upgrades/25/07/46637016/gileads-newly-approved-hiv-prevention-drug-poised-add-billions-future-sales
In June, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences, Inc.'s (NASDAQ:GILD) Yeztugo (lenacapavir) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV in adults and adolescents weighing at least 35kg, making it the first and only…
This story appeared on benzinga.com, 2025-07-25 16:12:33.